Vitura Health (ASX:VIT) might well fit the bill here - but just to prove that 'founder led' is not without its complications, one should witness the disgraceful 'two bulls at each other' performance leading up to the 2023 AGM in late November - a stoush which goes back some 18 months when a major holder/director is sacked for - quote - “repeated pattern of inappropriate behaviour, lack of judgment and poor performance”. Then there is an apparent 'love in" per announcement in November 2022 when warring parties reached a - quote - ‘positive resolution…enabling the Board and Management to focus on executing the company’s strategic objectives."
Not so - the bulls and their backers are back again with a section 249N notice to appoint their own and obviously get rid of the incumbents. One can only wonder at the dereliction of managerial duty this causes.
Throw in the fact that the Chair has resigned after a year to 'pusue personal interests' - ditto excuse of the previous Chair.
Said recent resigning Chair didn't buy one share, nor has her acting successor, who has been a director for some time - one would think if they saw an opportunity they might open their purse strings, but no.
Pity, if one just looks at the company accounts and the growth pattern, this one does excite - but, hey ho, as the Buffett-meister might say 'bad management will ruin a good company"
This is a stand aside for me until the clouds of doubt blow away. Doubtful, but maybe they should all take a swig, puff, sniff and snort of their own product and chill!.